hearing_witnesses: 24355

Witnesses who testified at committee hearings, with parsed name, title, organization, and location.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id package_id name title organization organization_normalized location
24355 CHRG-109hhrg29726 drug ``candidates'' identified by scientists   only 5 make it to clinical trials and only one of these, on average, will become a licensed product.2 The lack of support from the US government during the crucial intermediate stages of development results in premature failures of potential countermeasures as biopharma companies struggle to maintain operations through long periods of uncertainty without outside support. The priorities of the private capital markets, instead of the priorities of gove ONLY 5 MAKE IT TO CLINICAL TRIALS AND ONLY ONE OF THESE, ON AVERAGE, WILL BECOME A LICENSED PRODUCT.2 THE LACK OF SUPPORT FROM THE US GOVERNMENT DURING THE CRUCIAL INTERMEDIATE STAGES OF DEVELOPMENT RESULTS IN PREMATURE FAILURES OF POTENTIAL COUNTERMEASURES AS BIOPHARMA COMPANIES STRUGGLE TO MAINTAIN OPERATIONS THROUGH LONG PERIODS OF UNCERTAINTY WITHOUT OUTSIDE SUPPORT. THE PRIORITIES OF THE PRIVATE CAPITAL MARKETS, INSTEAD OF THE PRIORITIES OF GOVE